Clinical Trial Update: Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gemcitabine alone versus gemcitabine with capecitabine in locally advanced or metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Cancer Research UK | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED